Leadership Overview
Pharmascience has 4 executives leading key functions including strategy, marketing, quality assurance, and financial operations.
Driven by a commitment to global health, Pharmascience delivers affordable medications and innovative specialty treatments while maintaining rigorous regulatory standards across international pharmaceutical markets.
Driven by a commitment to global health, Pharmascience delivers affordable medications and innovative specialty treatments while maintaining rigorous regulatory standards across international pharmaceutical markets.
Leadership Roles at Pharmascience
Bhagaban Nahak - Chief Executive Officer
Bhagaban Nahak, the Chief Executive Officer at Pharmascience, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the manufacturing of nearly 300 molecules, the Chief Executive Officer ensures that all Canadian facilities maintain compliance with the highest global regulatory standards. This leadership role involves coordinating research and development investments in gastroenterology, orthopedics, and neurology to expand the company's specialty medication portfolio. By fostering partnerships with healthcare professionals, Bhagaban Nahak drives the mission of providing accessible treatments to patients worldwide. The Chief Executive Officer manages the integration of international market expansion with domestic production capabilities, ensuring consistent growth and operational excellence. Through strategic oversight of the entire pharmaceutical pipeline, the Chief Executive Officer secures the company's position as a leader in the generic and brand-name medication sectors, ultimately delivering value to stakeholders and patients alike.
Sonia Girolamo - Vice President, Finance & Chief Financial Officer
Sonia Girolamo, the Vice President, Finance & Chief Financial Officer at Pharmascience, directs the financial health and fiscal planning of the organization. Overseeing capital allocation for research and development, the Vice President, Finance & Chief Financial Officer ensures that investments in gastroenterology and other specialty areas align with long-term profitability goals. This role involves managing the financial risks associated with international operations and large-scale manufacturing. Sonia Girolamo coordinates with the executive team to optimize resource distribution across Canadian facilities, supporting the company's mission to provide affordable medications. By monitoring revenue streams and operational costs, the Vice President, Finance & Chief Financial Officer maintains the fiscal stability necessary for continuous innovation. The position requires precise financial reporting and strategic budgeting to support the company's expansion into new global markets. Through disciplined financial management, the Vice President, Finance & Chief Financial Officer enables the company to sustain its competitive edge and fulfill its commitment to healthcare professionals and patients.
Julie Riopel - Chief Marketing Officer, Spcialiste Aq
Julie Riopel, the Chief Marketing Officer, Spcialiste Aq at Pharmascience, architects the commercial outreach strategies for the company's diverse pharmaceutical portfolio. Focusing on the Canadian market, the Chief Marketing Officer, Spcialiste Aq develops tailored resources for healthcare professionals to improve patient outcomes. This role involves analyzing market trends to position generic and over-the-counter products effectively against competitors. Julie Riopel coordinates with internal teams to ensure that marketing communications align with strict regulatory guidelines and quality standards. By bridging the gap between complex pharmaceutical manufacturing and clinical application, the Chief Marketing Officer, Spcialiste Aq enhances brand visibility and product adoption. The position requires constant collaboration with sales departments to drive revenue growth across various therapeutic areas. Through data-driven campaigns and strategic engagement, the Chief Marketing Officer, Spcialiste Aq supports the broader corporate goal of increasing access to essential medications while maintaining the company's reputation for reliability and excellence.
Ananna Quadir - Quality Assurance Specialist & Chief Marketing Officer
Ananna Quadir, the Quality Assurance Specialist & Chief Marketing Officer at Pharmascience, manages the intersection of product integrity and market positioning. Overseeing the rigorous testing protocols required for pharmaceutical manufacturing, the Quality Assurance Specialist & Chief Marketing Officer ensures that every molecule produced meets international safety benchmarks. This role involves implementing advanced quality control systems that support the company's commitment to patient care. Ananna Quadir also directs the marketing initiatives for specialty medications, ensuring that promotional materials accurately reflect the clinical benefits of products in neurology and orthopedics. By maintaining high standards in both production and communication, the Quality Assurance Specialist & Chief Marketing Officer builds trust with healthcare providers and regulatory bodies. The position requires balancing technical compliance with commercial objectives to drive sustainable growth. Through meticulous oversight of quality processes, the Quality Assurance Specialist & Chief Marketing Officer protects the company's market standing and ensures the delivery of safe, effective treatments.
Explore Leadership Teams in Manufacturing
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership


TS
Curia, formerly AMRI, is a leading contract research, development and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers.
Company Leadership
JS
RA

Synokem Pharmaceuticals Ltd is a rising pharmaceutical organization established in 1983, specializing in contract manufacturing, ethical marketing, exports, and institutional supplies. The company aims to provide quality pharmaceutical products that are affordable to all sections of society, with a vision to become a world-class manufacturer. Synokem is committed to enhancing its market share through strategic alliances and collaborations, particularly in the international business sector. With a focus on research and development, the company is dedicated to achieving significant growth and establishing itself as an industry leader.
Company Leadership AK
SA
SS
Otsuka US is a healthcare company focused on improving health outcomes through innovative products and services in nephrology, immunology, and central nervous system disorders. They are dedicated to supporting patients, families, and healthcare providers with resources, advocacy, and clinical trials. Otsuka emphasizes unconventional thinking and perseverance in their mission to transcend expectations and serve the needs of others. Their commitment extends globally, collaborating with various stakeholders to enhance health worldwide.
Company Leadership TI

JB